NMD Pharma A/S
2 clinical trials · 2 recruiting · INDUSTRY
Trials by NMD Pharma A/S
RECRUITINGPhase 2NCT06414954
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
This Phase 2 proof-of-concept, dose range finding study aims to evaluate the safety and efficacy of 3 dose levels of NMD670 vs placebo in adult patients with MG with antibodies...
Sponsor: NMD Pharma A/SEnrolling: 8420 locations
Myasthenia GravisMyasthenia Gravis, MuSK
RECRUITINGPhase 2NCT05794139
Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of NMD670 in the treatment of ambulatory adults with spinal muscular atrophy type 3
Sponsor: NMD Pharma A/SEnrolling: 5420 locations
Spinal Muscular Atrophy